Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma

Journal of Neuro-Oncology

Volumn 41, Issue 2, 1999, Pages 167-174

  Ozaki, Satoshi ^a   Nishizaki, Takafumi ^a   Ito, Haruhide ^a   Sasaki, Kohsuke ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

CGH; Genetic alterations; Malignant progression; Meningioma

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 10; CHROMOSOME 1P; CHROMOSOME 20Q; CHROMOSOME 22; CHROMOSOME 2P; CHROMOSOME 4Q; CHROMOSOME 6Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; MENINGIOMA; MONOSOMY;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 22; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MONOSOMY; NUCLEIC ACID HYBRIDIZATION;

EID: 0032928725     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006086723607     Document Type: Article

References (52)

1. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumors. Brain Pathol 3: 255-268, 1993
2. Le May DR, Bucci MN, Farhat SM: Malignant transformation of recurrent meningioma with pulmonary metastases. Surg Neurol 31: 365-368, 1989
3. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL: Meningioma: analysis of reccurence and progression following neurosurgical resection. J Neurosurg 62: 18-24, 1985
4. Nowell PC: Cytogenetics of tumor progression. Cancer 65: 2172-2177, 1990
5. Atkinson L, Schmidek H: Genetic aspects of meningiomas, In: Schmidek H (ed): Meningiomas and their surgical management, Philadelphia, WB Sauders, 1991, pp. 42-47
6. Zankl H, Zang KD: Cytological and cytogenetical studies on brain tumors, iv. Identification of the missing G chromosome in human meningiomas as no. 22 by fluorescence technique. Hum Genet 14: 167-169, 1972
7. Rey JA, Bello MJ, de Campos JM, Kusak E, Moreno S: Chromosomal involvement secondary to -22 in human meningiomas. Cancer Genet Cytogenet 33: 275-290, 1988
8. Vagner-Capodano AM, Grisoli F, Gambarelli D, Sedan R, Pellet W, De Victor B: Correlation between cytogenetic and histopathological findings in 75 human meningiomas. Neurosurgery 32: 892-900, 1993
9. Lekanne Deprez RH, Riegman PH, van Drunen E, Warringa UL, Groen NA, Stefanko SZ, Koper JW, Avezaat CJ, Mulder PG, Zwarthoff EC, Hagemeijer A: Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuropath Exp Neurol 54: 224-235, 1995
10. Bello MJ, De Campos JM, Kusak ME, Vaquera J, Sarasa JL, Pestana A, Rey JA: Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes & Cancer 9: 296-298, 1994
11. Lindblom A, Ruttledge M, Collins VP, Nordenskjöld M, Dumanski JP: Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Int J Cancer 56: 354-357, 1994
12. Rempel SA, Schwechheimer K, Davis RL, Cavenee WK, Rosenblum ML: Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 53: 2386-2392, 1993
13. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992
14. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Nat Acad Sci USA 91: 2156-2160, 1994
15. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM: Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33: 955-963, 1993
16. Rohringer M, Sutherland GR, Louw DF, Sima AA: Incidence and clinicopathological features of meningioma. J Neurosurg 71: 665-672, 1989
17. Jaaskelainen J, Haltia M, Servo A: Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surgical Neurol 25: 233-242, 1986
18. Palma L, Celli P, Franco C, Cervoni L, Cantore G: Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86: 793-800, 1997
19. Nishizaki T, Devries S, Chew K, Goodson-lii WH, Ljung BM, Thor A, Waldman FM: Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes & Cancer 19: 267-272, 1997
20. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N, Waldman FM: Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 74: 513-517, 1997
21. Nishizaki T, Ozaki S, Harada K, Ito H, Arai H, Beppu T, Sasaki K: Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosomes & Cancer 21: 340-346, 1998
22. Ozaki S, Shiraishi K, Oga A, Uesugi N, Kurose A, Nakao K, Horiike Y, Sasaki K: The development of software for comparative genomic hybridization (CGH) analysis. Yamaguchi Medical Journal 45: 377-383, 1996
23. Maltby EL, Ironside JW, Battersby RD: Cytogenetic studies in 50 meningiomas. Cancer Genet Cytogenet 31: 199-210, 1988
24. Mark J, Levan G, Mitelman F: Identification of the G chromosome lost in human meningiomas. Hereditas 71: 163-168, 1972
25. Dumanski JP, Rouleau GA, Nordenskjöld M, Collins VP: Molecular genetic analysis of chromosome 22 in 81 cases of meningiomal. Cancer Res 50: 5863-5867, 1990
26. Lekanne DR, Riegman PH, Groen NA, Warringa UL, Van Biezen NA, Molijn AC, Bootsma D, De Jong PJ, Menon AG, Kley NA: Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 10: 1521-1528, 1995
27. Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U: Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 95: 347-351, 1995
28. Rey JA, Bello MJ, De Campos JM, Vaquero J, Kusak ME, Sarasa JL, Pestaña A: Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches. Cancer Genet Cytogenet 66: 1-10, 1993
29. Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, Von Deimling A: Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Amer J Pathol 146: 827-832, 1995
30. Poulsgård L, Ronne M, Schroder HD: Cytogenetic studies of 19 meningiomas and their clinical significance. Anticancer Res 9: 109-112, 1989
31. Poulsgård L, Schroder HD, Ronne M: Cytogenetic studies of 11 meningiomas and their clinical significance II. Anticancer Res 10: 535-538, 1990
32. Casalone R, Granata P, Simi P, Tarantino E, Butti G, Buonaguidi R, Faggionato F, Knerich R, Solero L: Recessive cancer genes in meningiomas? An analysis of 31 cases. Cancer Genet Cytogenet 27: 145-159, 1987
33. Schneider BF, Shashi V, Von Kap-Herr C, Golden WL: Loss of chromosomes 22 and 14 in the malignant progression of meningiomas. A comparative study of fluorescence in situ hybridization (FISH) and standard cytogenetic analysis. Cancer Genet Cytogenet 85: 101-104, 1995
34. Simon M, Von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JJ, Menon AG: Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55: 4696-4701, 1995
35. Bello MJ, Vaquero J, De Campos JM, Kusak ME, Sarasa JL, Saez-Castresana J, Pestaña A, Rey AR: Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 57: 172-175, 1994
36. Mulligan LM, Gardner E, Smith BA, Mathew CGP, Ponder BAJ: Genetic events in tumor initiation and progression in multiple endocrine neoplasia type 2. Genes Chromosomes & Cancer 6: 166-177, 1994
37. Leister I, Weith A, Bruderlein S, Czieoluch C, Kangwanpong D, Schlag P, Schwab M: Human colorectal cancer: high frequency of deletions at chromosome 1p35. Cancer Res 50: 7232-7235, 1990
38. Yeh SH, Chen PJ, Chen HL, Lai MY, Wang CC, Chen DS: Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 54: 4188-4192, 1994
39. Bièche I, Champème MH, Matifas F, Cropp CS, Callahan R, Lidereau R: Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res 53: 1990-1994, 1993
40. Mathew S, Murty VVVS, Bosl GJ, Chaganti RSK: Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res 54: 6265-6269, 1994
41. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE, Kefford RF: Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86: 4614-4618, 1989
42. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR: Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q and 9p in human malignant mesothelioma. Cancer Res 53: 4349-4355, 1993
43. Brodeur GM, Green AA, Haynes FA, Williams KJ, Williams DL, Tsiatis AA: Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41: 4678-4686, 1981
44. Niedermayer I, Feiden W, Henn W, Steilen-Gimbel H, Steudel WI, Zang KD: Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropath Exp Neurol 56: 879-886, 1997
45. Al Saadi A, Latimer M, Madercic M, Robbins T: Cytogenetic studies of human brain tumors and their clinical significance. II. Meningioma. Cancer Genet Cytogenet 26: 127-141, 1987
46. Katsuyama J, Papenhausen PR, Herz F, Gazivoda P, Hirano A, Koss LG: Chromosome abnormalities in meningiomas. Cancer Genet Cytogenet 22: 63-68, 1986
47. Dumanski JP, Carlbom E, Collins VP, Nordenskjöld M: Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci USA 84: 9275-9279, 1987
48. Kim DH, Mohapatra C, Bollen A, Waldman FM, Feuerstein BG: Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer 60. 812-819, 1995
49. Rodabaugh KI, Blanchard G, Welch WR, Bell DA, Berkowitz RS, Mok SC: Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors. Cancer Res 55: 2169-2172, 1995
50. Perry A, Jenkins RB, Dahl RJ, Moertel CA, Scheithauer BW: Cytogenetic analysis of aggressive meningiomas: possible diagnostic and prognostic implications. Cancer 77: 2567-2573, 1996
51. Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K, Du Manoir S, Auer G: Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes & Cancer 15: 234-245, 1996
52. Weber RG, Sommer C, Albert FK, Kiessling M, Cremer T: Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab Invest 74: 108-119, 1996